<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>Tyrosine increases Colorectal Cancer Tissue — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>Tyrosine</strong>
  <span class="pred">&mdash;increases&rarr;</span>
  <strong>Colorectal Cancer Tissue</strong>
</div>
<div class="entity-id">HMDB:HMDB0000158 &nbsp;&middot;&nbsp; MESH:D015179</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:0%;--color:#d62728"></div>
<div class="stat-row">
  <span>Class: AI Generated (0.01)</span>
  <span>Replicated: 1 paper</span>
  <span>Score: 21.77<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; Curated 0.5 &middot; AI 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts 0.8). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">SCORE BREAKDOWN</p>
<hr class="section-rule">
<div class="score-breakdown">Base weight: 0.01 (AI Generated, 1 paper)<br>Score from 35 citations: <strong>21.77</strong><br><span style="color:#888">2&times; extends (+1.20) &middot; 6&times; supports (+3.00) &middot; 27&times; contradicts (+17.57)</span></div>


<p class="section-label">EVIDENCE CHAIN &middot; 1 source</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#d62728" title="AI Generated"></span><span>AI Generated</span><a href="https://doi.org/10.1053/j.gastro.2019.03.020">10.1053/j.gastro.2019.03.020</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 35 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:22px"></span><span>6</span><span class="cite-subtotal">&middot; +3.00</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">aromatic amino acid gut microbiota-derived metabolites — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/b63179e81c7f8dad.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">DG 40:4 — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/8a08715790ab7156.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">polar metabolite profile — distinguishes → early-onset colorectal cancer vs late-onset colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/48da7f4765f2f00a.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">D-alanine — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/7ade234f30987916.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">D-glutamine — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/c803b8a43209a47f.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">D-serine — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/88dfe84c85051aa0.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:100px"></span><span>27</span><span class="cite-subtotal">&middot; +17.57</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">choline — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+3.20</span><a href="../claim/80b56d22c3e762c6.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">alanine — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+4.14</span><a href="../claim/4799c6376c53277f.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">p-cresol — distinguishes → colorectal cancer</span><span class="cite-claim-weight">+0.63</span><a href="../claim/f85cc0e4c3d671a6.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">β-hydroxybutyrate — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.40</span><a href="../claim/80a3bb84628584af.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">β-hydroxybutyrate — causes → Colorectal Cancer metastasis</span><span class="cite-claim-weight">+0.40</span><a href="../claim/d1e0c98faf30c65c.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">β-hydroxybutyrate — activates → ACAT1</span><span class="cite-claim-weight">+0.40</span><a href="../claim/f40d998842d494b8.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">ACAT1 — increases → IDH1 acetylation</span><span class="cite-claim-weight">+0.40</span><a href="../claim/6f4344faf80fc494.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">ACAT1 silencing — decreases → Colorectal Cancer progression</span><span class="cite-claim-weight">+0.40</span><a href="../claim/b3bf217e0eba7f4a.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">β-hydroxybutyrate — distinguishes → Colorectal Cancer</span><span class="cite-claim-weight">+0.40</span><a href="../claim/d5765d1ef3b40cb5.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">GLPG1690 — decreases → colorectal cancer proliferation</span><span class="cite-claim-weight">+0.40</span><a href="../claim/54ed74b292b57969.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">ENPP2 gene knockdown — decreases → colorectal cancer proliferation</span><span class="cite-claim-weight">+0.40</span><a href="../claim/209bcd72ceca390a.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">GLPG1690 — increases → claudin-1</span><span class="cite-claim-weight">+0.40</span><a href="../claim/e34f0052e25d69b0.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">GLPG1690 — increases → occludin</span><span class="cite-claim-weight">+0.40</span><a href="../claim/da451b74be2fb2a2.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">GLPG1690 — increases → ZO-1</span><span class="cite-claim-weight">+0.40</span><a href="../claim/ab39e19ef39878e5.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">GLPG1690 — decreases → M2 tumor-associated macrophage polarization</span><span class="cite-claim-weight">+0.40</span><a href="../claim/236e765e155fbae1.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">GLPG1690 — decreases → colonic inflammation</span><span class="cite-claim-weight">+0.40</span><a href="../claim/4afb5c0c106b409d.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">GLPG1690 — treats → colorectal cancer</span><span class="cite-claim-weight">+0.40</span><a href="../claim/4f7139b1825d9461.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">ENPP2 — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.40</span><a href="../claim/64e5ad5f36211dab.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">GLPG1690 — activates → gut barrier function</span><span class="cite-claim-weight">+0.40</span><a href="../claim/48484358a16224ff.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">gut microbiota composition — predicts → GLPG1690 efficacy</span><span class="cite-claim-weight">+0.40</span><a href="../claim/d4126029e35ad072.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">uridine — distinguishes → early-onset colorectal cancer vs late-onset colorectal cancer</span><span class="cite-claim-weight">+0.40</span><a href="../claim/1126bd03de802f8e.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">lipid profile — distinguishes → early-onset colorectal cancer vs late-onset colorectal cancer</span><span class="cite-claim-weight">+0.40</span><a href="../claim/307dadf04e4cc7ee.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">D-α-aminobutyric acid — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.40</span><a href="../claim/5642e770cf570b3f.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Combined panel: D-AABA + L-Ala + D-Ala + D-Gln + D-Ser — distinguishes → Colorectal Cancer vs Healthy Controls</span><span class="cite-claim-weight">+0.40</span><a href="../claim/27d577b98e53f32e.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Combined panel: D-AABA + D-Ala + D-Gln + D-Ser — distinguishes → Colorectal Cancer vs Healthy Controls</span><span class="cite-claim-weight">+0.40</span><a href="../claim/c51e8d71188dd1ae.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">D-methionine — decreases → Colorectal Cancer (age &gt; 50)</span><span class="cite-claim-weight">+0.40</span><a href="../claim/387f0fc1691bcb5e.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">D/L-Glutamine ratio — correlates_with → Colorectal Cancer Stage IV vs Stage I</span><span class="cite-claim-weight">+0.40</span><a href="../claim/9e0fe767d557ec3a.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:7px"></span><span>2</span><span class="cite-subtotal">&middot; +1.20</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">β-hydroxybutyrate — increases → Colorectal Cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/99704819a5c90b01.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">β-hydroxybutyrate — causes → Colorectal Cancer proliferation</span><span class="cite-claim-weight">+0.60</span><a href="../claim/658ba6d39aa569c3.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>70efd0d7784207cf</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/HMDB:HMDB0000158">HMDB:HMDB0000158</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/MESH:D015179">MESH:D015179</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
